Literature DB >> 17931106

Antibody neutralization and viral virulence in recurring dengue virus type 2 outbreaks.

Sook-San Wong1, Juraina Abd-Jamil, Sazaly Abubakar.   

Abstract

Outbreaks involving dengue viruses (DENV) of the same genotype occur in a cyclical pattern in Malaysia. Two cycles of outbreaks involving dengue virus type 2 (DENV-2) of the same genotype occurred in the 1990s in the Klang Valley, Malaysia. Sera of patients from the first outbreak and sera of mice inoculated with virus from the same outbreak had poorer neutralization activity against virus of the second outbreak. Conversely, patient sera from the second outbreak showed higher neutralization titer against virus of the early outbreak. At subneutralizing concentrations, sera of mice immunized with second outbreak virus did not significantly enhance infection with viruses from the earlier outbreak. Amino acid substitution from valine to isoleucine at position 129 of the envelope protein (E), as well as threonine to alanine at position 117 and lysine to arginine at position 272 of the NS1 protein, differentiated viruses of the two outbreaks. These findings highlight the potential influence of specific intragenotypic variations in eliciting varied host immune responses against the different DENV subgenotypes. This could be an important contributing factor in the recurring homogenotypic dengue virus outbreaks seen in dengue-endemic regions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17931106     DOI: 10.1089/vim.2006.0100

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  13 in total

1.  Antibodies induced by dengue virus type 1 and 2 envelope domain III recombinant proteins in monkeys neutralize strains with different genotypes.

Authors:  Lidice Bernardo; Osmel Fleitas; Alequis Pavón; Lisset Hermida; Gerardo Guillén; Maria G Guzman
Journal:  Clin Vaccine Immunol       Date:  2009-09-02

2.  Seroprevalence of Zika Virus among Forest Fringe Communities in Peninsular Malaysia and Sabah: General Population-Based Study.

Authors:  Hooi-Yuen Khoo; Hai-Yen Lee; Chee-Sieng Khor; Kim-Kee Tan; Mohd Rohaizat Bin Hassan; Chin Mun Wong; Hani Kartini Agustar; Nadia Aqilla Samsusah; Syed Sharizman Syed Abdul Rahim; Mohd Saffree Bin Jeffree; Nur Athirah Yusof; Noor Ain Haron; Zarina Binti Amin; Rozita Hod; Sazaly AbuBakar
Journal:  Am J Trop Med Hyg       Date:  2022-07-25       Impact factor: 3.707

3.  The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1.

Authors:  Yang Zhou; S Kyle Austin; Daved H Fremont; Boyd L Yount; Jeremy P Huynh; Aravinda M de Silva; Ralph S Baric; William B Messer
Journal:  Virology       Date:  2013-02-28       Impact factor: 3.616

4.  Extract of Scutellaria baicalensis inhibits dengue virus replication.

Authors:  Keivan Zandi; Tong-Hye Lim; Nor-Aziyah Rahim; Meng-Hooi Shu; Boon-Teong Teoh; Sing-Sin Sam; Mohammed-Bashar Danlami; Kim-Kee Tan; Sazaly Abubakar
Journal:  BMC Complement Altern Med       Date:  2013-04-29       Impact factor: 3.659

5.  Review of Dengue hemorrhagic fever fatal cases seen among adults: a retrospective study.

Authors:  Sing-Sin Sam; Sharifah Faridah Syed Omar; Boon-Teong Teoh; Juraina Abd-Jamil; Sazaly AbuBakar
Journal:  PLoS Negl Trop Dis       Date:  2013-05-02

6.  Novel antiviral activity of baicalein against dengue virus.

Authors:  Keivan Zandi; Boon-Teong Teoh; Sing-Sin Sam; Pooi-Fong Wong; Mohd Rais Mustafa; Sazaly Abubakar
Journal:  BMC Complement Altern Med       Date:  2012-11-09       Impact factor: 3.659

7.  Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope.

Authors:  S Kyle Austin; Kimberly A Dowd; Bimmi Shrestha; Christopher A Nelson; Melissa A Edeling; Syd Johnson; Theodore C Pierson; Michael S Diamond; Daved H Fremont
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

8.  Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells.

Authors:  Meng Ling Moi; Chang-Kweng Lim; Kaw Bing Chua; Tomohiko Takasaki; Ichiro Kurane
Journal:  PLoS Negl Trop Dis       Date:  2012-02-28

9.  Antiviral activity of four types of bioflavonoid against dengue virus type-2.

Authors:  Keivan Zandi; Boon-Teong Teoh; Sing-Sin Sam; Pooi-Fong Wong; Mohd Rais Mustafa; Sazaly Abubakar
Journal:  Virol J       Date:  2011-12-28       Impact factor: 4.099

10.  Autochthonous spread of DENV-3 genotype III in Malaysia mitigated by pre-existing homotypic and heterotypic immunity.

Authors:  K K Tan; S Nellis; N I Zulkifle; S Sulaiman; S AbuBakar
Journal:  Epidemiol Infect       Date:  2018-06-04       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.